Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Latest revision entries (Aug 2026) were added to the page's history, including 2026-08-26, 2026-08-24, and 2026-08 with Revision: v3.6.6. An older revision entry (Revision: v3.6.5) was removed from the history.
    Difference
    0.2%
    Check dated 2026-09-01T19:44:34.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    Two new NIH grant/contract entries (2019 and 2023) were added to the study's identifiers, updating the funding references associated with the trial.
    Difference
    0.1%
    Check dated 2026-08-25T21:30:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page shows a new release version tag (v3.6.5) replacing the previous v3.6.4. This indicates an internal update to the site template or backend rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-08-11T19:48:30.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the study details page.
    Difference
    0.0%
    Check dated 2026-07-21T13:37:46.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.6.0 to v3.6.3, indicating a minor page/version update. This change is a metadata/versioning update and does not modify substantive content or study details.
    Difference
    0.0%
    Check dated 2026-06-30T00:39:21.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The study locations count was updated to 85 locations, down from 86, indicating a reduction in participating sites and reflecting the current geographic footprint of the trial.
    Difference
    0.2%
    Check dated 2026-06-22T22:58:20.000Z thumbnail image

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.